Genscript Biotech to spin off unit in $100m Nasdaq IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Asia

Genscript Biotech to spin off unit in $100m Nasdaq IPO

Jonathan Breen
May 14, 2020 06:30 AM
pills adobe stock 575x375 pharmaceuticals

Genscript Biotech Corp is planning to spin-off and list subsidiary Legend Biotech Corp in a potential $100m Nasdaq IPO. The firm submitted listing documents to the US regulator on Wednesday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganEquity IPOsHealth and BiotechEquityAmericasJefferies LLCHong Kong SARAsiaGreater ChinaMorgan StanleyNortheast AsiaAsia PacificUnited StatesEmerging MarketsNorth AmericaSRI
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article